Roche · 3 days ago
Postdoctoral Fellow - Enzyme Technologies
Wonder how qualified you are to the job?
BiotechnologyHealth Care
Insider Connection @Roche
Responsibilities
Design and conduct laboratory experiments to discover and characterize novel enzymes for epigenetic sequencing solutions.
Analyze data independently and collaborate with established teams to guide project decisions.
Contribute to the preparation of scientific publications and patent applications.
Communicate complex issues clearly to various audiences across functions and levels.
Qualification
Find out how your skills align with this job's requirements. If anything seems off, you can easily click on the tags to select or unselect skills to reflect your actual expertise.
Required
A Ph. D. in the Biological Sciences (molecular & cellular biology, biochemistry, biophysics, structural biology, chemistry) or related disciplines with relevant first-author publications
Proficient with protein engineering tools and processes, including target identification, construction of diverse mutant libraries, protein expression and purification, and candidate screening
Experienced with PCR, library preparation technologies, and workflows for epigenetic / epigenomic NGS (EM-seq, MRE-seq, bisulfite sequencing, etc). Familiarity with whole-genome, RNA-Seq, multi-omic, and/or single-cell sequencing applications is a plus
Excited to collaborate with system engineers, computational biologists, and statisticians to develop new protocols and algorithms for sequencing data analysis. Knowledge of software and computational tools like Python, C++, R, JMP, and/or AlphaFold are beneficial
Benefits
Relocation benefits
Company
Roche
Roche is a pharmaceutical and diagnostics company that focuses on improving people’s lives. It is a sub-organization of Roche France.
Funding
Current Stage
Public CompanyTotal Funding
$7.79BKey Investors
SoftBankSCALE AINovartis
2021-08-04Post Ipo Equity· $5B
2020-05-06Post Ipo Equity· $0.5M
2010-01-01Post Ipo Equity· Undisclosed
Leadership Team
Recent News
2024-06-01
Company data provided by crunchbase